Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.sandu.in | |
Market Cap | 59.22 Cr. | |
Enterprise Value(EV) | 55.41 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 1.18 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 52.04 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.97 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 32.73 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 1.87 | Calculated using Price: 61.30 |
Dividend Yield | 1.22 | Period Ending 2023-03 |
No. of Shares Subscribed | 0.97 Cr. | 9,660,990 Shares |
FaceValue | 10 | |
About Sandu Pharmaceuticals Ltd. | ||
Sandu Pharmaceuticals incorporated in 1985, is engaged in manufacturing of ayurvedic medicines. The company operates a distribution network in India as well as in the overseas markets. |
1 Day |
|
-1.97% |
1 Week |
|
|
1 Month |
|
+2.81% |
3 Month |
|
-12.15% |
6 Month |
|
-0.40% |
1 Year |
|
+7.97% |
2 Year |
|
-24.51% |
5 Year |
|
+185.88% |
10 Year |
|
+601.70% |
1 years | 2023-03 | |
Return on Equity (%) | 5 | |
Return on Capital Employed (%) | 7.55 | |
Return on Assets (%) | 2.81 |
Particulars | 2 years | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 39 | 40 | |
Non Curr. Liab. | 1 | 1 | |
Curr. Liab. | 14 | 12 | |
Minority Int. | |||
Equity & Liab. | 54 | 53 | |
Non Curr. Assets | 29 | 28 | |
Curr. Assets | 26 | 25 | |
Misc. Exp. not W/O | |||
Total Assets | 54 | 53 |
Particulars | 2 years | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 65 | 67 | |
Other Income | 0 | 0 | |
Total Income | 66 | 67 | |
Total Expenditure | -63 | -65 | |
PBIDT | 3 | 2 | |
Interest | 0 | 0 | |
Depreciation | -1 | -1 | |
Taxation | -1 | -1 | |
Exceptional Items | |||
PAT | 2 | 1 | |
Minority Interest | |||
Share Associate | |||
Other Related Items | |||
Consolidated Net Profit | 2 | 1 | |
Adjusted EPS | 2 | 1 |
Particulars | 1 years | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | |
Cash Fr. Inv. | 1 | |
Cash Fr. Finan. | 1 | |
Net Change | 1 | |
Cash & Cash Eqvt | 2 |
Thu, 25 Apr 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate stop transfer for duplicate issue of share certificate |
Wed, 24 Apr 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Stop Transfer for Duplicate issue of Share Certificate |
Wed, 17 Apr 2024
Compliance Under Regulation 40(9) Of SEBI (LODR) Compliance under Regulation 40(9) for the Year ended 31st March 2024 |
Fri, 26 Apr 2024 |
High Delivery Percentage |
Opening at High |
Closing Below Previous Low |
High Decrease in 3 Months |
High Increase in 5 Years |